Marco S. S.
- Country
- Spain
- Department
- 2103: Oftalmología
Research Overview
- Open-Label Rollover Study of AMG 732 in Thyroid Eye Disease Nonresponders and Relapsed Participants
- Evaluation of Satralizumab Efficacy and Safety in Moderate-to-Severe Thyroid Eye Disease: A Phase III Randomized, Double-Masked, Placebo-Controlled Study
- Evaluation of Batoclimab Efficacy and Safety in an Open-Label Extension Study for Thyroid Eye Disease Treatment in Participants Completing IMVT-1401-3201/3202
Data & Insights
Has run more than one trial at 73 of 158 partner sites.
Specializations
Ophthalmology and thyroid eye disease
Clinical research in ophthalmology with a strong focus on thyroid eye disease, including active involvement in studies of moderate-to-severe disease and related orbital inflammation.
- Thyroid eye disease
- Acquired blepharoptosis
- Graves’ disease
- Ocular myasthenia gravis
Interest also extends to eye-related autoimmune and inflammatory conditions that affect vision and orbital function.
Breast cancer and gynecologic oncology
Research activity includes a broad therapeutic commitment to breast cancer, especially hormone receptor-positive and HER2-directed treatment settings, alongside major involvement in gynecologic cancers.
- Hormone receptor-positive breast cancer
- HER2-positive breast cancer
- Triple-negative breast cancer
- Ovarian cancer
- Endometrial cancer
Additional interest is seen in cervical cancer, uterine carcinosarcoma, and other advanced solid tumors with unmet therapeutic need.
Genitourinary oncology and thoracic malignancies
The investigator is actively involved in treatment development for urothelial carcinoma, renal cell carcinoma, prostate cancer, and lung cancer, with emphasis on advanced and metastatic disease.
- Urothelial carcinoma
- Renal cell carcinoma
- Prostate cancer
- Non-small cell lung cancer
- Small cell lung cancer
Work also covers biomarker-defined tumors and recurrent disease requiring novel systemic options.
Hematologic malignancies and cell therapy
Clinical interests include lymphoma, multiple myeloma, acute myeloid leukemia, and other blood cancers, with participation in studies of immune-based and targeted treatment strategies.
- Diffuse large B-cell lymphoma
- Follicular lymphoma
- Multiple myeloma
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
Research also includes gene-modified T-cell approaches and other advanced immuno-oncology platforms.
Autoimmune, cardiometabolic, and neurologic disease
Beyond oncology, the investigator is involved in studies of autoimmune disease, cardiovascular disease, metabolic disorders, and selected neurologic conditions.
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Heart failure
- Atherosclerotic cardiovascular disease
- Multiple sclerosis
Therapeutic interest also includes inflammatory bowel disease, liver disease, and chronic inflammatory disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.